Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166 - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Nature Communications Année : 2020

Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166

Résumé

While several clathrin-independent endocytic processes have been described so far, their biological relevance often remains elusive, especially in pathophysiological contexts such as cancer. In this study, we find that the tumor marker CD166/ALCAM (Activated Leukocyte Cell Adhesion Molecule) is a clathrin-independent cargo. We show that endophilin-A3-but neither A1 nor A2 isoforms-functionally associates with CD166-containing early endocytic carriers and physically interacts with the cargo. Our data further demonstrates that the three endophilin-A isoforms control the uptake of distinct subsets of cargoes. In addition, we provide strong evidence that the construction of endocytic sites from which CD166 is taken up in an endophilin-A3-dependent manner is driven by extracellular galectin-8. Taken together, our data reveal the existence of a previously uncharacterized clathrin-independent endocytic modality, that modulates the abundance of CD166 at the cell surface, and regulates adhesive and migratory properties of cancer cells.
Fichier principal
Vignette du fichier
s41467-020-15303-y.pdf (2.1 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

inserm-02619135 , version 1 (25-05-2020)

Identifiants

Citer

Henri-François Renard, François Tyckaert, Cristina Lo Giudice, Thibault Hirsch, Cesar Augusto Valades-Cruz, et al.. Endophilin-A3 and Galectin-8 control the clathrin-independent endocytosis of CD166. Nature Communications, 2020, 11 (1), pp.1457. ⟨10.1038/s41467-020-15303-y⟩. ⟨inserm-02619135⟩
98 Consultations
76 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More